These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21033041)

  • 1. Plotting a strategy. Interview by Jeff Berry.
    Lewin S
    Posit Aware; 2010; 22(5):30-1. PubMed ID: 21033041
    [No Abstract]   [Full Text] [Related]  

  • 2. Stalemate--but not checkmate. An expert takes on the challenges. Interview by Jeff Berry.
    Cohen C
    Posit Aware; 2010; 21(2):56-8. PubMed ID: 20524352
    [No Abstract]   [Full Text] [Related]  

  • 3. One-on-one: Mardge Cohen. A Chicago doctor making a difference in Rwanda. Interview by Jeff Berry.
    Cohen M
    Posit Aware; 2006; 17(2):25-6. PubMed ID: 16610123
    [No Abstract]   [Full Text] [Related]  

  • 4. 14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry.
    Eron JJ
    Posit Aware; 2007; 18(3):31-3. PubMed ID: 17526114
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV agents. The changing picture of HIV.
    TreatmentUpdate; 2009 Feb; 21(2):1-3. PubMed ID: 19391260
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. What makes a viral load blip?
    TreatmentUpdate; 2008 Jan; 20(1):4. PubMed ID: 18320693
    [No Abstract]   [Full Text] [Related]  

  • 8. Deadly risk of drug-resistant HIV.
    Gulland A
    Nurs Times; 2000 Dec 7-13; 96(49):6. PubMed ID: 11965965
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug maestro: 20 years on the trail of HIV. An interview with Martin S. Hirsch. Interview by Mark Mascolini.
    Hirsch MS
    IAPAC Mon; 2001 Apr; 7(4):104-9, 113. PubMed ID: 11700604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strategies for the use of anti-retroviral agents in HIV infection (1997). Extracts from the 4th Dormont Report].
    Rev Pneumol Clin; 1998 Feb; 54(1):9-16. PubMed ID: 9769979
    [No Abstract]   [Full Text] [Related]  

  • 11. The church of viral suppression.
    Huff B
    GMHC Treat Issues; 2005; 19(9-11):1-9. PubMed ID: 16541505
    [No Abstract]   [Full Text] [Related]  

  • 12. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advance on targets and drugs for anti-HIV].
    Wang X; Ma H; Wen R
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1454-9. PubMed ID: 19771882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound of HIV-1 viral load after suppression to very low levels.
    Staszewski S; Miller V; Sabin C; Berger A; Hill AM; Phillips AN
    AIDS; 1998 Dec; 12(17):2360. PubMed ID: 9863886
    [No Abstract]   [Full Text] [Related]  

  • 15. One-on-one with Joe Eron, M.D. An update on Isentress (raltegravir) data, including some unexpected results. Interview by Jeff Berry.
    Eron J
    Posit Aware; 2009; 20(3):46-7. PubMed ID: 19492451
    [No Abstract]   [Full Text] [Related]  

  • 16. [HIV mutant M184V. Benefits of a mutation].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():53-4. PubMed ID: 11373783
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

  • 18. Yale University begins novel clinical anti-HIV therapy.
    AIDS Patient Care STDS; 1996 Dec; 10(6):376. PubMed ID: 11361559
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicians' discussion: trends in HIV care.
    Braun J; el-Sadr W; Merrick S; Rubin D; Vogler M; Frost KR
    AIDS Read; 2000 Apr; 10(4):233-40. PubMed ID: 10808606
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
    Posit Aware; 2006; Spec No():17-22. PubMed ID: 16596730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.